Ashton Tweed Connection Vol. 4 No. 4

Featuring CEO Interview with Elizabeth Hanna, President, Human Health, and Chief Operating Officer, Origin

Your Issue of Ashton Tweed Connection Vol. 4 No. 4 is Here! Our Site Contact us

CEO Leadership Series: Elizabeth Hanna, President, Human Health, and Chief Operating Officer, Origin Elizabeth “Betsy” Hanna spent much of her career with large organizations – including pharma giants Bristol-Myers Squibb and Johnson & Johnson – where she ran the company’s Europe, Mideast and Africa diagnostics business while… Read More

Case Study: Interim Quality Director Jumps Right Into Start-Up A pharmaceutical start-up in Pennsylvania was looking to file an NDA in the spring of 2017. The client had previously hired a quality consultant who was too junior and didn’t fit well with their company culture… Read More   Blog: 3 Ways to Support Your Leader to Success Although your leadership team may consist of one individual or a few people, it doesn’t mean they are meant to work alone. Successful leaders often rely on a team of advisors or trusted peers within or without their company. Having worked… Read More

Don’t miss out on top hiring news! Ashton Tweed’s Weekly Digest email covers hiring, firing, & retiring news in the life sciences. Also, check out our: Featured Candidates Upcoming Events Recent Editions Subscribe Now!   TIME 100: The Most Influential People Features George Church George Church is featured in TIME Magazine‘s annual list, TIME 100: The Most Influential People of 2017, under the category of “Titans.” TIME‘s excerpt on Church is written by none other than Stephen Colbert, host of CBS’s… Read More   Pricing furor aside, drug spending growth slowed last year Despite news about drug pricing expenses last year, net spending growth actually fell in the US. After discounts, pharma spending increased 4.8% in 2016, down from 8.9% growth in 2015. These numbers come from… Read More   5 trends shaping rare disease drug development Amid criticism of rising prescription drug costs, the 1983 Orphan Drug Act, which granted drugmakers of a rare disease drug seven years of marketing exclusivity, has become a hot topic. Increased investment in rare dis… Read More   Scott Gottlieb confirmed to lead FDA The Senate confirmed Scott Gottlieb, a physician and venture capitalist, as the next commissioner of the Food and Drug Administration (FDA). The vote was 57 to 42. Gottlieb previously served as a deputy FDA commissioner and an official at the… Read More

Featured Event: BIO International Convention When: June 19-22, 2017 Where: San Diego, CA The Biotechnology Innovation Organization (BIO) represents over 1,100 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the world… Read More

FDA clears new ALS drug for US Market The FDA has approved Radicava in the US as the first new drig since 1995 to treat ALS. It will be marketed by MT Pharma America, a division of Mitsubishi Tanabe Pharma. Radicava’s US price is expected to be $145,000, significantly… Read More INC Research and inVentiv Health merge Quintiles and IMS Health combined in a megamerger last year, and now INC and inVentiv are doing the same, making it the second largest biopharmaceutical outsourcing provider in the world. The two CROs will combine in an all-stock… Read More

About Ashton Tweed, Ltd. At the very core of Ashton Tweed’s talent-acquisition and talent-placement business is a robust professional force of highly experienced life sciences industry experts. These uniquely talented professionals are deployed throughout Ashton Tweed’s diverse range of service offerings to solve our clients’ human capital and management needs. Contact Ashton Tweed 565 E. Swedesford Rd. Suite 214 Wayne, PA 19087P: 610.725.0290 F: 610.975.0291 E: info@ashtontweed.com ©2017 Ashton Tweed. All rights reserved.